<p> </p><p>In previous studies the carboxyl-terminus of microtubule-associated protein 1S was shown to interact with the <em>N</em>-methyl-D-aspartate receptor subunit NR3A (Eriksson <em>et. al.</em>)¹.  In this study, interactions between three truncations of the microtubule-associated proteins 1B and one truncation of the microtubule-associated protein 1S carboxyl-terminus and the <em>N</em>-methyl-D-aspartate receptor subunits NR1 and NR3A were examined. The study showed that an interaction occurred between amino acids 2167 to 2365 of the microtubule-associated protein 1B and NR3A.  That region of microtubule associated protein 1B corresponds to a microtubule-binding region in the light chain. It has been shown in earlier studies (Reviewed in Halpain S. <em>et a1²</em>, Riederer, BM<em>.  et.al³</em>.) that the light chain is a active part of the protein that have been post translational cleaved. The MAP 1 proteins are present in all tissue but has higher concentrations in the Post Synaptic Density of neurons in the central nervous system.  The <em>N</em>-methyl-D-aspartate receptors are present in glial cells and in the dendritic shafts of the central nervous system neurons (Eriksson <em>et. al.</em>)¹. The diseases were these proteins may play a part is mainly memory destructive diseases such as Alzheimers disease and in muscular dystrophy, but these assumptions are still being speculated.</p><p> </p>

In previous studies the carboxyl-terminus of microtubule-associated protein 1S was shown to interact with the N-methyl-D-aspartate receptor subunit NR3A (Eriksson et. al.)1.  In this study, interactions between three truncations of the microtubule-associated proteins 1B and one truncation of the microtubule-associated protein 1S carboxyl-terminus and the N-methyl-D-aspartate receptor subunits NR1 and NR3A were examined. The study showed that an interaction occurred between amino acids 2167 to 2365 of the microtubule-associated protein 1B and NR3A.  That region of microtubule associated protein 1B corresponds to a microtubule-binding region in the light chain. It has been shown in earlier studies (Reviewed in Halpain S. et a12, Riederer, BM.  et.al3.) that the light chain is a active part of the protein that have been post translational cleaved. The MAP 1 proteins are present in all tissue but has higher concentrations in the Post Synaptic Density of neurons in the central nervous system.  The N-methyl-D-aspartate receptors are present in glial cells and in the dendritic shafts of the central nervous system neurons (Eriksson et. al.)1 . The diseases were these proteins may play a part is mainly memory destructive diseases such as Alzheimers disease and in muscular dystrophy, but these assumptions are still being speculated.

Introdução: Os receptores ionotrópicos do glutamato, como o N-metil-D-Aspartato (NMDA), estão envolvidos em desordens psiquiátricas. NMDARs são complexos heteroméricos que incorporam tres diferentes subunidades: NR1, NR2 e NR3. Objetivos: quantificar os níveis plasmáticos das subunidades NR1 e NR2 NMDAR em pacientes em primeiro episódio psicótico (PEP), em comparação com os irmãos e controles saudáveis. Métodos: Este é um estudo transversal de PEP na região de Ribeirão Preto, Brasil, sendo o grupo controle composto por indivíduos saudáveis, pareados por idade, sexo e mesma área de abrangência dos casos. Foram coletados 5 mL de amostra de sangue próxima a data de diagnóstico de PEP. A quantificação plasmática das subunidades NR1 e NR2 foi realizada por ELISA. Os dados foram analisados por ANOVA (significante se p<0,05) e curva ROC. Resultados: Foram incluídos 166 pacientes em PEP (idade: x = 30,34 ± 12,2 anos; 64% homens), destes 84 com diagnóstico de psicose não afetiva, 51 com transtorno bipolar e 31 com transtorno depressivo. Foram tambem incluídos 76 irmãos e 166 controles saudáveis. Os níveis plasmáticos das subunidades NR1 e NR2 foram significativamente menores em pacientes com transtornos psicóticos (NR1: x = 71,0 ± 100,3 pg/mL, NR2: x = 2,5 ± 2 ng/ml), transtorno bipolar (NR1: x = 185,7 ± 319,5 pg/ml; NR2: x = 2,1 ± 2,2 ng/ml), transtorno depressivo (NR1: x = 83,2 ±185,0 pg/ml; NR2: x = 2,1± 2,1 ng/ml) em comparação com os irmãos (NR1: x = 140,6 ± 193,8 pg/ml; NR2: = 6,2 ± 1,5 ng/ml) e voluntários saudáveis (NR1: x = 146,7 ± 361,1 pg/ml; NR2: x = 4,8 ± 2,2 ng/ml) [NR1 e NR2, p < 0,001]. Indivíduos com valores plasmáticos de NR2 inferiores a 3,648 ng/mL apresentam um risco 14,72 vezes maior de estar doente (PEP) de quem não possui o NR2 abaixo deste valor. Conclusões: Este é o primeiro estudo relatando a quantificação e a redução das concentrações plasmaticas das subunidades NR1 e NR2 em transtornos psiquiátricos graves quando comparados aos irmãos e controles, podendo a subunidade NR2 ser um candidato a biomarcador plasmático em pacientes com PEP. / Background: Ionotropic glutamate receptors, such as N-Methyl-D-Aspartate (NMDA), are involved in pathophysiology of several psychiatric disorders. NMDARs are described as heteromeric complexes incorporating distincts subunits within a repertoire of three types: NR1, NR2 and NR3. Aim: to quantify the NR1 and NR2 subunits NMDAR plasma levels in patients with first episode psychosis (FEP), compared with siblings and healthy controls. Methods: This is a cross-sectional study of FEP conducted in Ribeirão Preto, Brazil. The control group were composed by healthy subjects matched for age, sex and same coverage area of cases. 5 ml of blood sample were collected next to the date of FEP diagnosis. NR1 and NR2 subunits plasmatic quantification was performed by ELISA. Data were analyzed by ANOVA (significant at p < 0.05) and ROC curve. Results: FEP sample comprised 166 patients (age: x = 30.34 ± 12.2 years; 64% men), of these 84 with a diagnosis of psychotic disorder, 51 with bipolar disorder and 31 with depressive disorder. It was also included 76 siblings and 166 healthy controls. NR1 and NR2 subunits plasma levels were significantly lower in patients with psychotic disorders (NR1: x = 71.0 ± 100.3 pg / ml, NR2: x = 2.5 ± 2 ng/ml), bipolar disorder (NR1: x = 185.7 ± 319.5 pg/mL; NR2: x = 2.1 ± 2.2 ng/ml), depressive disorders (NR1: x = 83.2 ± 185.0 pg/mL; NR2: x = 2.1 ± 2.1 ng/ml) compared with siblings (NR1: x = 140.6 ± 193.8 pg/mL; NR2: x = 6.2 ± 1.5 ng/ml) and healthy volunteers (NR1: x = 146.7 ± 361.1 pg / mL; NR2: x = 4.8 ± 2.2 ng/ml) [NR1 and NR2, p < 0.001]. Interestingly, individuals with NR2 plasma values less than 3.648 ng/ml present 14.72 times a higher risk to be in FEP than other patients. Conclusions: This is the first study reporting the measurement and reduction of NR1 and NR2 subunits plasma concentrations in severe psychiatric disorders when compared to siblings and controls. And highlighting that NR2 subunit can be a candidate for plasma biomarker in patients with FEP.

Introdução: Os receptores ionotrópicos do glutamato, como o N-metil-D-Aspartato (NMDA), estão envolvidos em desordens psiquiátricas. NMDARs são complexos heteroméricos que incorporam tres diferentes subunidades: NR1, NR2 e NR3. Objetivos: quantificar os níveis plasmáticos das subunidades NR1 e NR2 NMDAR em pacientes em primeiro episódio psicótico (PEP), em comparação com os irmãos e controles saudáveis. Métodos: Este é um estudo transversal de PEP na região de Ribeirão Preto, Brasil, sendo o grupo controle composto por indivíduos saudáveis, pareados por idade, sexo e mesma área de abrangência dos casos. Foram coletados 5 mL de amostra de sangue próxima a data de diagnóstico de PEP. A quantificação plasmática das subunidades NR1 e NR2 foi realizada por ELISA. Os dados foram analisados por ANOVA (significante se p<0,05) e curva ROC. Resultados: Foram incluídos 166 pacientes em PEP (idade: x = 30,34 ± 12,2 anos; 64% homens), destes 84 com diagnóstico de psicose não afetiva, 51 com transtorno bipolar e 31 com transtorno depressivo. Foram tambem incluídos 76 irmãos e 166 controles saudáveis. Os níveis plasmáticos das subunidades NR1 e NR2 foram significativamente menores em pacientes com transtornos psicóticos (NR1: x = 71,0 ± 100,3 pg/mL, NR2: x = 2,5 ± 2 ng/ml), transtorno bipolar (NR1: x = 185,7 ± 319,5 pg/ml; NR2: x = 2,1 ± 2,2 ng/ml), transtorno depressivo (NR1: x = 83,2 ±185,0 pg/ml; NR2: x = 2,1± 2,1 ng/ml) em comparação com os irmãos (NR1: x = 140,6 ± 193,8 pg/ml; NR2: = 6,2 ± 1,5 ng/ml) e voluntários saudáveis (NR1: x = 146,7 ± 361,1 pg/ml; NR2: x = 4,8 ± 2,2 ng/ml) [NR1 e NR2, p < 0,001]. Indivíduos com valores plasmáticos de NR2 inferiores a 3,648 ng/mL apresentam um risco 14,72 vezes maior de estar doente (PEP) de quem não possui o NR2 abaixo deste valor. Conclusões: Este é o primeiro estudo relatando a quantificação e a redução das concentrações plasmaticas das subunidades NR1 e NR2 em transtornos psiquiátricos graves quando comparados aos irmãos e controles, podendo a subunidade NR2 ser um candidato a biomarcador plasmático em pacientes com PEP. / Background: Ionotropic glutamate receptors, such as N-Methyl-D-Aspartate (NMDA), are involved in pathophysiology of several psychiatric disorders. NMDARs are described as heteromeric complexes incorporating distincts subunits within a repertoire of three types: NR1, NR2 and NR3. Aim: to quantify the NR1 and NR2 subunits NMDAR plasma levels in patients with first episode psychosis (FEP), compared with siblings and healthy controls. Methods: This is a cross-sectional study of FEP conducted in Ribeirão Preto, Brazil. The control group were composed by healthy subjects matched for age, sex and same coverage area of cases. 5 ml of blood sample were collected next to the date of FEP diagnosis. NR1 and NR2 subunits plasmatic quantification was performed by ELISA. Data were analyzed by ANOVA (significant at p < 0.05) and ROC curve. Results: FEP sample comprised 166 patients (age: x = 30.34 ± 12.2 years; 64% men), of these 84 with a diagnosis of psychotic disorder, 51 with bipolar disorder and 31 with depressive disorder. It was also included 76 siblings and 166 healthy controls. NR1 and NR2 subunits plasma levels were significantly lower in patients with psychotic disorders (NR1: x = 71.0 ± 100.3 pg / ml, NR2: x = 2.5 ± 2 ng/ml), bipolar disorder (NR1: x = 185.7 ± 319.5 pg/mL; NR2: x = 2.1 ± 2.2 ng/ml), depressive disorders (NR1: x = 83.2 ± 185.0 pg/mL; NR2: x = 2.1 ± 2.1 ng/ml) compared with siblings (NR1: x = 140.6 ± 193.8 pg/mL; NR2: x = 6.2 ± 1.5 ng/ml) and healthy volunteers (NR1: x = 146.7 ± 361.1 pg / mL; NR2: x = 4.8 ± 2.2 ng/ml) [NR1 and NR2, p < 0.001]. Interestingly, individuals with NR2 plasma values less than 3.648 ng/ml present 14.72 times a higher risk to be in FEP than other patients. Conclusions: This is the first study reporting the measurement and reduction of NR1 and NR2 subunits plasma concentrations in severe psychiatric disorders when compared to siblings and controls. And highlighting that NR2 subunit can be a candidate for plasma biomarker in patients with FEP.

NMDARs are indispensable for developmental plasticity in the mammalian brain, but their roles in vivo are difficult to ascertain as NMDAR-knockouts are lethal. To circumvent this problem, we utilized NR1-knockdown mice to examine plasticity at the calyx of Held-MNTB synapse in the auditory brainstem. Previous work shows NMDARs at this synapse are rapidly down-regulated following the onset of hearing (P12), leading to the hypothesis that transient NMDAR expression is indispensable for modulating functional and morphological remodelling during development. We tested this by performing electrophysiological recordings, fluorescence tracing in vitro, and auditory brainstem responses in vivo, and surprisingly found that reducing postsynaptic NMDARs appears to promote functional maturation via presynaptic mechanisms in the absence of morphological and acoustic transmission differences in the mature calyx. This suggests a novel role for NMDARs to function as an activity-dependent control for setting the pace of consolidation and maturation in the calyx of Held synapse.

NMDARs are indispensable for developmental plasticity in the mammalian brain, but their roles in vivo are difficult to ascertain as NMDAR-knockouts are lethal. To circumvent this problem, we utilized NR1-knockdown mice to examine plasticity at the calyx of Held-MNTB synapse in the auditory brainstem. Previous work shows NMDARs at this synapse are rapidly down-regulated following the onset of hearing (P12), leading to the hypothesis that transient NMDAR expression is indispensable for modulating functional and morphological remodelling during development. We tested this by performing electrophysiological recordings, fluorescence tracing in vitro, and auditory brainstem responses in vivo, and surprisingly found that reducing postsynaptic NMDARs appears to promote functional maturation via presynaptic mechanisms in the absence of morphological and acoustic transmission differences in the mature calyx. This suggests a novel role for NMDARs to function as an activity-dependent control for setting the pace of consolidation and maturation in the calyx of Held synapse.

Στον αμφιβληστροειδή επιτελείται η μετατροπή δηλαδή της φωτεινής ενέργειας σε ηλεκτρικό ερέθισμα. Κύριος διεγερτικός διαβιβαστής στον αμφιβληστροειδή είναι το γλουταμινικό οξύ του οποίου η δράση επιτελείται μέσω ιοντοτρόπων, NMDA και μη NMDA, και μεταβοτρόπων υποδοχέων. Οι υποδοχείς ΝΜDA παρουσιάζουν ιδιαίτερα χαρακτηριστικά, όπως μεγάλη αγωγιμότητα ασβεστίου και τασεοεξαρτώμενη αναστολή από το Μg, ενώ φαίνεται να παίζουν ιδιαίτερο ρόλο σε διαδικασίες συναπτικής πλαστικότητας, στην ανάπτυξη του νευρικού συστήματος καθώς και στην διεγερσιτοξικότητα του γλουταμινικού. Στον αμφιβληστροειδή εντοπίζονται κυρίως στα γαγγλιακά και βραχύϊνα κύτταρα αλλά και σε διάμεσους νευρώνες. Οι υποδοχείς NMDA είναι ετερομερή που αποτελούνται από τις υπομονάδες NR1, NR2 και NR3. Το γονίδιο της βασικής λειτουργικής υπομονάδας NR1 περιέχει τρία εξόνια τα οποία υφίστανται εναλλακτικό μάτισμα προς δημιουργία οχτώ ισομορφών. Οι ισομορφές που περιλαμβάνουν το εξόνιο 21 ή C1 στο καρβοξυτελικό άκρο έχουν την χαρακτηριστική ιδιότητα φωσφορυλίωσης στην θρεονίνη 879 και στις σερίνες 890, 896 και 897. Η φωσφορυλίωση αποτελεί έναν από τους κυριότερους μηχανισμούς ρύθμισης των υποδοχέων του γλουταμινικού οξέος επηρεάζοντας τις ιδιότητες τους, την μεταφορά τους προς την κυτταρική μεμβράνη, αλλά και την υποκυτταρική κατανομή των υπομονάδων τους. Στόχος της εργασίας είναι η μελέτη της φωσφορυλιωμένης υπομονάδας NR1 του υποδοχέα NMDA στις θέσεις σερίνης 896 και 897 (NR1-Ser896 και NR1-Ser897) κατά την ανάπτυξη στον αμφιβληστροειδή. Για τον σκοπό αυτό χρησιμοποιήσαμε επίμυες Wistar ηλικιών 9, 14, 21, 35 και 60 ημερών. Με την μέθοδο ανοσοαποτύπωσης κατά Western μελετήσαμε τα επίπεδα της φωσφορυλιωμένης πρωτείνης. Η ΝR1-Ser897 παρουσιάζει ένα πρότυπο αύξησης μέχρι και την ηλικία των 35 ημερών με επακόλουθη πτώση σε αυτήν των 60 ημερών. Η NR1-Ser896 αυξάνεται μέχρι την ηλικία των 14 ημερών όπου και παρουσιάζει μια σταθερή πορεία μέχρι την ηλικία των 60 ημερών. Συμπερασματικά, οι φωσφορυλιώσεις στις διαφορετικές σερίνες της υπομονάδας NR1 του υποδοχέα NMDA παρουσιάζουν διαφορετικό αναπτυξιακό προφίλ και γενικότερα η φωσφορυλίωση αυτής της υπομονάδας φαίνεται ότι ρυθμίζεται αναπτυξιακά στον αμφιβληστροειδή. / The retina is responsible for the light conversion into nerve signals. Glutamate is the major excitatory neurotransmitter in the retina. Its actions are mediated by glutamate ionotropic (NMDA and non NMDA) and metabotropic receptors. The NMDA receptors (NMDARs) are permeable to Ca++ and are unique among glutamate receptors in that they are blocked by Mg++ in a voltage dependent manner. These receptors also seem to play an important role in the development of the nervous system, in synaptic plasticity as well as in glutamate neurotoxicity. In the retina they are expressed in many ganglion and amacrine cells and occasionally in horizontal and glial cells. Functional NMDARs are heteromers composed of the NR1 NR2 and NR3 subunits. The gene of the NR1 subunit has three exons which undergo alternative splicing to generate theoretically eight NR1 splice variants. Half of them include the exon 21 or C1 in carboxy-terminus domain which can be phosphorylated in the following residues: threonine 879 and serines 890,896 and 897. Protein phosphorylation has been recognized as a major mechanism for the regulation of glutamate receptor function, changing their properties and because of its proposed role in trafficking and targeting of the NMDARs, as well as in clustering NR1 subunits into receptor-rich domains. The aim of the present work is to study the phosphorylated subunit NR1 at the serine residues 896 and 897 of the NMDAR (NR1-Ser896 and NR1-Ser897) during retinal development. Wistar rats at postnatal days 9, 14, 21, 35 and 60 are used for the developmental studies. The protein levels of the phosphorylated NR1 subunit were evaluated in Western blots. NR1-Ser897 increased gradually with a peak value observed at postnatal day 35, followed by a decrease at P60. NR1-Ser 896 was also increased to its peak level at the age of 14 and its levels sustained until the age of 60.These data reveal that the developmental profiles of the phoshorylated NR1 subunits at the serine residues 896 and 897 are different, and that the phosphorylation of the NR1 subunit is, in general, subject to regulation during development of the retina

Excitotoxicity is the overexcitation of neurons due to the excessive activation of excitatory amino acid receptors and is thought to be involved in many neurodegenerative states. The manner in which the neuron breaks down during excitotoxicity is still unclear. The current study used the organotypic hippocampal slice culture model to examine the time-dependent loss of the synaptic vesicular protein synaptophysin and the loss of N-methyl-D-aspartate (NMDA) receptor NR1 subunit availability following an excitotoxic insult (20 μM NMDA) to provide a better understanding of the topographical nature of neuronal death following NMDA receptor activation. Significant NMDA-induced cytotoxicity in the CA1 region of the hippocampus (as measured by propidium iodide uptake) was evident early (15 minutes after exposure) while significant loss of the NR1 subunit and synaptophysin was found at later timepoints (72 and 24 hours, respectively), suggesting delayed downregulation or degradation in axons and dendrites as compared to the soma. The addition of the competitive NMDA receptor antagonist 2-amino-7-phosphonovaleric acid (APV) significantly attenuated all NMDA-induced effects. These results suggest that NR1 and synaptophysin levels as measured by immunoreactivity are not reliable indicators of early cell death.

No description available.